Cargando…
GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells
Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer that commonly arises through neuroendocrine differentiation (NED) of prostate adenocarcinoma (PAC) after therapy, such as radiation therapy and androgen deprivation treatment (ADT). No effective therapeutic is availabl...
Autores principales: | Sang, Meixiang, Hulsurkar, Mohit, Zhang, Xiaochong, Song, Haiping, Zheng, Dayong, Zhang, Yan, Li, Min, Xu, Jianming, Zhang, Songlin, Ittmann, Michael, Li, Wenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216714/ https://www.ncbi.nlm.nih.gov/pubmed/27191986 http://dx.doi.org/10.18632/oncotarget.9359 |
Ejemplares similares
-
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
por: Zhang, Yan, et al.
Publicado: (2018) -
Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST
por: Li, Wenliang, et al.
Publicado: (2023) -
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation
por: Wang, Zheng, et al.
Publicado: (2021) -
Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019) -
GRK2 Enforces Androgen Receptor-Dependence in the Prostate and Prostate Tumors
por: Adler, Adam J., et al.
Publicado: (2020)